![]() |
시장보고서
상품코드
1619282
세계의 웨어러블 주사기 시장 - 규모, 점유율, 성장 분석 : 유형별, 기술별, 적응증별, 최종 사용자별, 지역별 업계 예측(2024-2031년)Wearable Injectors Market Size, Share, Growth Analysis, By Type (On-body, Off-body), By Technology (Spring-Based, Motor Drive), By Indications, By End User, By Region - Industry Forecast 2024-2031 |
웨어러블 주사기 세계 시장 규모는 2022년에 66억 6,000만 달러로 평가되었고, 2023년 76억 5,000만 달러에서 2031년에는 238억 9,000만 달러로 확대되어 예측 기간(2024-2031년)의 CAGR은 15.29%로 나타날 것으로 예상됩니다.
웨어러블 주사기는 환자와 헬스케어 종사자 모두의 안전성을 높이고, 주사 바늘의 삽입이나 제거 등의 종래의 주사 방법에 따른 리스크를 대폭 경감함으로써 환자 케어에 혁명을 가져오고 있습니다. 선진국가, 개발도상국을 불문하고 의료비가 급등하고 있는 가운데, 이 혁신적인 주사기는 고품질로 저렴한 의료를 제공하기 위한 해결책을 제시하고 있습니다 환자는 집에서 편리하게 피하 주사를 할 수 있고 병원에 통원 또는 관련 비용을 줄일 수 있습니다. 사용자 친화적인 디자인의 주사기는 사용자가 버튼으로 장치를 작동시킬 수 있으며 원활한 바늘 삽입을 보장합니다. 자동으로 끌어들이기 때문에 바늘 찌르기로 인한 부상 가능성은 없습니다.
Global Wearable Injectors Market size was valued at USD 6.66 billion in 2022 and is poised to grow from USD 7.65 billion in 2023 to USD 23.89 billion by 2031, growing at a CAGR of 15.29% in the forecast period (2024-2031).
Wearable injectors are revolutionizing patient care by enhancing safety for both patients and healthcare workers, significantly mitigating risks associated with traditional injection methods, such as needle insertion and removal. As healthcare costs rise in both developed and developing nations, these innovative injectors present a solution for delivering high-quality, affordable care. Patients can administer subcutaneous injections conveniently at home, reducing hospital visits and associated costs. With a user-friendly design, the injector allows users to activate the device with a button, ensuring seamless needle insertion. After medication delivery, the device retracts the needle automatically, eliminating the possibility of needle stick injuries. This advanced technology not only enhances safety but also streamlines the injection process, making it an essential component of modern healthcare.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Wearable Injectors market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Wearable Injectors Market Segmental Analysis
Global Wearable Injectors Market is segmented by Type, Technology, Indications, End User and region. Based on Type, the market is segmented into On-body Wearable Injectors, Off-body Wearable Injectors, Device-Only Wearable Injectors. Based on Technology, the market is segmented into Spring-Based, Motor Drive, Expanding Battery, Rotary Pump, Other. Based on Indications, the market is segmented into Diabetes, Immuno- Oncology, Cardiovascular, Chronic Pain. Based on End User, the market is segmented into Hospital & Clinic, Homecare, Other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Wearable Injectors Market
The growing prevalence of chronic diseases significantly fuels the expansion of the wearable injectors market. With a rise in the number of patients suffering from conditions such as diabetes, cardiovascular diseases, and cancer, the demand for these devices is surging. Wearable injectors offer a more convenient and less painful method for medication administration, which enhances patient adherence to treatment regimens. As the global burden of chronic illnesses escalates, particularly among the aging population, the adoption of wearable injectors is projected to rise. This trend reflects a broader shift toward innovative healthcare solutions that prioritize patient comfort and compliance.
Restraints in the Global Wearable Injectors Market
A significant constraint facing the global wearable injectors market is the elevated pricing associated with these devices. The integration of advanced technology and intricate manufacturing processes contributes to their high cost, rendering them less accessible to many users. This economic barrier presents a considerable challenge, particularly in developing and low-income regions, where affordability becomes a critical issue. As a result, the high prices of wearable injectors can hinder widespread adoption and limit market growth, creating disparities in access to these innovative healthcare solutions in different parts of the world.
Market Trends of the Global Wearable Injectors Market
The Global Wearable Injectors market is witnessing a significant trend towards personalized medicine, driven by the increasing development of biopharmaceutical products tailored to individual patient needs. As healthcare providers and manufacturers focus on delivering customized treatment regimens, wearable injectors are evolving to accommodate personalized medication delivery systems. This shift enhances patient outcomes by ensuring greater adherence and accuracy in drug administration. Furthermore, the rising demand for patient-centric solutions is revitalizing the market, fostering innovation in wearable injector technology that aligns with the broader trend of precision medicine, ultimately shaping the future of therapeutic delivery in healthcare.